Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,313 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07129096Enrolling by invitation
Digital relaxation training for jaw pain
This study tests if a digital relaxation program can help reduce jaw pain caused by temporomandibular disorders (TMD). It may be a good option if you have jaw muscle or joint pain and want to try a non-drug approach.
OuluAges Any age - NCT07131631Recruiting
MitraClip for leaky heart valve in heart failure patients
This trial tests if the MitraClip device helps people with heart failure and a leaky mitral valve. It uses a special MRI to check how the heart responds to treatment.
Minneapolis, MinnesotaAges 18 years+ - NCT07133958Recruiting
Testing NAIC for advanced mouth and throat cancer
This study looks at how well NAIC treatment helps shrink advanced mouth or throat cancer. It aims to find patterns in how tumors respond to treatment.
Guangzhou, GuangdongAges 18–80 - NCT07134881Recruiting
Navigating serious illness with digital care planning
This trial tests a digital tool to help people with serious illnesses and their caregivers plan future medical care. It may help you discuss your goals and treatments with your doctor and family.
SingaporeAges 21 years+ - NCT07128927Recruiting
Web-based insomnia treatment for prostate cancer survivors
This trial tests a web-based program to help Black/African American men with prostate cancer who have trouble sleeping. You'll learn strategies to improve your sleep without using medication.
Washington D.C., District of ColumbiaAges 21 years+ - NCT07126769Recruiting
Cyberchondria and stress in women having infertility treatment
This study looks at how searching for health information online (cyberchondria) and stress levels affect women who are going through infertility treatments like IUI, IVF, or ICSI. It may help you understand your own experiences and contribute to better care.
Istanbul, AtaşehirAges 18–45 - NCT07131514RecruitingPhase 2
Combination therapy for pancreatic cancer before and after surgery
This trial tests if giving a combination of four drugs before and after surgery can help treat pancreatic cancer. The drugs include HRS-4642, gemcitabine, nab-paclitaxel, and adebrelimab. It may help shrink the tumor before surgery and lower the chance of cancer coming back afterward.
ShanghaiAges 18–80 - NCT07133438RecruitingPhase 4
Vitamin B12 with eye injections for blocked retinal vein
This trial tests if adding mecobalamin (a form of vitamin B12) to standard anti-VEGF eye injections helps people with vision loss caused by a blocked vein in the retina. You must have swelling in the back of the eye and have had no prior treatments for this condition.
ChongqingAges 18–80 - NCT07132190RecruitingPhase 2
Radiation for growing brain tumors with same-day planning
This study tests whether a precise, one-day radiation treatment for brain tumors that are growing or in tricky spots can be effective with a smaller safety margin. It's designed for people whose brain tumors are changing quickly or sitting near areas of swelling or recent surgery.
Boston, MassachusettsAges 18 years+ - NCT06240559Recruiting
Brachytherapy treatment verification study
This study checks if doctors can better verify brachytherapy (a type of internal radiation) during treatment for gynecological or prostate cancer. It may help improve accuracy and outcomes for patients receiving this therapy.
Maastricht, LimburgAges Any age - NCT05938192Recruiting
Treatments for HPV-related genital tract changes
This trial studies treatment approaches for conditions caused by human papillomavirus (HPV) in the female genital tract. It may help people whose HPV-related disease is being evaluated for new or combined treatment options.
Milan, LombardyAges 18 years+ - NCT06252935Recruiting
Collagen membrane for gum and bone repair
This trial tests a new collagen membrane (FormaAid®) for repairing gum and bone damage from gum disease. It may help people with deep gum pockets and bone loss who are not smokers and have well-controlled health conditions.
Taipei, TaiwanAges 18–70 - NCT06932471RecruitingPhase 3
Study of a new drug for PNH patients with anemia despite current treatment
This trial tests a new pill (MY008211A) for people with paroxysmal nocturnal hemoglobinuria (PNH) who still have low red blood cell counts (anemia) even after taking anti-C5 antibody therapy. The goal is to see if this new drug can raise hemoglobin levels and improve energy.
Beijing, Beijing MunicipalityAges 18–75 - NCT06207110Recruiting
Family support program for children with high food responsiveness
This study tests a program for families with children ages 7–12 who have overweight or obesity and often feel strong urges to eat. The program helps parents support their child in eating healthier and being more active.
La Jolla, CaliforniaAges 7–12 - NCT07118241RecruitingPhase 2
Testing a new eye drop for Sjögren's dry eye
This trial tests a new eye drop made from a natural protein (rhPRG4) to see if it safely and effectively relieves dry eye symptoms in people with Sjögren's syndrome. You'll be randomly assigned to receive the study drop or a placebo (inactive) drop for several weeks.
Sydney, New South WalesAges 18–80 - NCT07118254RecruitingPhase 2
Eye drops for dry eye from graft-versus-host disease
This study tests whether a new eye drop (rhPRG4) can safely reduce dry eye symptoms caused by graft-versus-host disease (GVHD). It compares the active drops to an inactive placebo to see if they provide better relief.
Sydney, New South WalesAges 18–75 - NCT07124078RecruitingPhase 2
Study of axatilimab for young people with chronic graft-versus-host disease
This study tests a new drug called axatilimab for children and teens with chronic graft-versus-host disease (cGVHD) that hasn't improved with standard treatments. The goal is to see if axatilimab works better than the usual care options. Participants will be randomly assigned to receive either axatilimab or one of several standard treatments.
Duarte, CaliforniaAges 2–17 - NCT07123129RecruitingPhase 1
Study of SHR-7782 for advanced solid tumors
This trial tests a new drug called SHR-7782 for people with advanced cancers that have not responded to other treatments. It aims to see if the drug is safe and can shrink tumors.
Beijing, Beijing MunicipalityAges 18–75 - NCT07122401RecruitingPhase 3
Study of MT1013 for dialysis patients with high parathyroid hormone
This trial tests a new medicine called MT1013 for people with secondary hyperparathyroidism who are on dialysis. It may help control high parathyroid hormone levels when current treatments are not enough.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07123402Enrolling by invitationPhase 2
TRD205 for chronic pain after surgery
This trial tests a new tablet called TRD205 for people who have had long-lasting nerve pain after surgery (at least 3 months). The goal is to see if it can reduce pain safely.
BeijingAges 18–80 - NCT07123727RecruitingPhase 2
Testing Anktiva for long COVID symptoms
This study tests if the drug Anktiva can help people with long COVID. To join, you must have had at least one confirmed COVID-19 infection and now have lasting symptoms that started or got worse after that infection.
El Segundo, CaliforniaAges 18–70 - NCT06295263Recruiting
AI for diagnosing and treating brain diseases in older adults
This study uses artificial intelligence to help diagnose and treat brain diseases that affect older adults, such as Parkinson's and Alzheimer's. Researchers will compare AI methods with standard care to see if they can improve diagnosis and treatment.
Jinan, ShandongAges 8–100 - NCT07122895RecruitingPhase 2
NMDA enhancer for negative symptoms in schizophrenia
This study tests whether a medication that boosts brain NMDA receptors can improve negative symptoms in schizophrenia, and looks at differences between men and women. It is for people with stable schizophrenia who still have mostly flat mood or low motivation.
TaichungAges 20–65 - NCT07125235Recruiting
Support program for HIV treatment adherence
This trial tests a program to help people with HIV stay on track with their medication. If you take HIV medication, sometimes miss doses, and use stimulants, this program may offer support to improve your health.
San Francisco, CaliforniaAges 18–70
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,313 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.